Size :50ug
Clone Number:
Aliases:Calcium/calmodulin dependent protein kinase beta antibody; Calcium/calmodulin dependent protein kinase kinase 2 antibody; Calcium/calmodulin dependent protein kinase kinase 2 beta antibody; Calcium/calmodulin dependent protein kinase kinase beta antibody; Calcium/calmodulin-dependent protein kinase kinase 2 antibody; Calcium/calmodulin-dependent protein kinase kinase beta antibody; CaM kinase kinase beta antibody; CaM KK beta antibody; CaM-kinase kinase 2 antibody; CaM-kinase kinase beta antibody; CaM-KK 2 antibody; CaM-KK beta antibody; CaMKK 2 antibody; CAMKK antibody; CaMKK beta antibody; CAMKK beta protein antibody; Camkk2 antibody; CAMKKB antibody; KKCC2_HUMAN antibody
Product Type:Polyclonal Antibody
Immunogen Species:Homo sapiens (Human)
UniProt ID:Q96RR4
Immunogen:Recombinant Human Calcium/calmodulin-dependent protein kinase kinase 2 protein (5-148AA)
Raised in:Rabbit
Species Reactivity:Human
Tested Applications:ELISA, IHC; Recommended dilution: IHC:1:20-1:200
Background:Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. Efficiently phosphorylates 5′-AMP-activated protein kinase (AMPK) trimer, including that consisting of PRKAA1, PRKAB1 and PRKAG1. This phosphorylation is stimulated in response to Ca(2+) signals (By similarity). Seems to be involved in hippocampal activation of CREB1 (By similarity). May play a role in neurite growth. Isoform 3 may promote neurite elongation, while isoform 1 may promoter neurite branching.
Clonality:Polyclonal
Isotype:IgG
Purification Method:>95%, Protein G purified
Conjugate:Non-conjugated
Buffer:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form:Liquid
Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Names:CAMKK2
Research Areas:Cancer; Signal transduction